Runben Biotechnology Co

Runben Biotechnology Co AAQS

The The AAQS of Runben Biotechnology Co (603193.SS) as of Oct 20, 2026 is 5. In the previous year, The AAQS was 5.00 — a change of 0.00% (lower).

AAQS

5

YoY

0.00%

Last updated:

Runben Biotechnology Co has a current AAQS of 5.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Runben Biotechnology Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Runben Biotechnology Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2019
5.00 CNY
Jan 1, 2020
5.00 CNY
Jan 1, 2021
5.00 CNY
Jan 1, 2022
5.00 CNY
Jan 1, 2023
5.00 CNY
Jan 1, 2024
5.00 CNY
Jan 1, 2025
5.00 CNY
The Runben Biotechnology Co AAQS history
YEARAAQSYoY
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
5—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Runben Biotechnology Co Stock analysis

What does Runben Biotechnology Co do? Runben Biotechnology Co., Ltd. generates revenue through the research, development, manufacture, and sale of mosquito repellent, baby care, and personal care products. The company's main product categories include electric mosquito repellent liquid, DEET mosquito repellent liquid, lipstick, face cream, facial cleanser, and skin care cream, which are sold via online direct sales, online platform distribution, and online platform agency sales. These products target domestic consumers in China, with the firm focusing on internet-based sales channels to reach its customer base. The company's product portfolio spans mosquito repellent solutions, baby care items, and essential oil products, with key offerings such as DEET mosquito repellent liquid and electric mosquito repellent liquid driving sales. Baby care products and personal care items like lipstick and face cream are distributed through online platforms, leveraging digital channels to serve the domestic market. Runben Biotechnology emphasizes direct consumer engagement through e-commerce platforms to facilitate product distribution. Runben Biotechnology's revenue streams are derived from the sale of its core product lines, including mosquito repellent products, baby care products, and essential oil products. The firm's domestic market focus ensures that its products, such as facial cleanser and skin care cream, are tailored to local consumer preferences. Online sales models, including direct online sales and platform agency sales, form the primary channel for product delivery to end-users. Runben Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Runben Biotechnology Co stock

The AAQS of Runben Biotechnology Co is 5 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Runben Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Runben Biotechnology Co

All Key Metrics — Runben Biotechnology Co